Loading company…
TaiLai Biosciences, based in Shenzhen, develops liquid biopsy products for early cancer screening and diagnosis.
Founded in 2018 and based in Shenzhen, China, TaiLai Biosciences focuses on research and development of cancer screening technologies. Its flagship product, Meta-Pan® (An'an Pan®), gives early risk warning for 14 common cancer types in China, and it serves medical institutions, insurance organizations and individual consumers. In December 2020 the company raised approximately CNY 100 million in Series A funding.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in